TrialCancer immunology, immunotherapy : CII2014

The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.

Peggy J de Vos van Steenwijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.